Diphtheria antitoxin 10,000units/10ml solution for injection ampoules
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Diphtheria antitoxin
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Diphtheria antitoxin
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 13 · Randomised trials: 1 · 1909–2026
Showing the 50 most relevant studies, sorted by most relevant.
Polonsky J, Hudu S, Uthman K, et al.
2026
Nasir Abdulrasheed, Lukman Lawal, A. B. Mogaji, et al.
Immunity, Inflammation and Disease, 2023
- Diphtheria
- Corynebacterium
- Diphtheria Antitoxin
Marta Prygiel, E. Mosiej, M. Polak, et al.
Toxins, 2024
- Diphtheria
- Diphtheria Toxin
- Corynebacterium
Octora TN, Estari S, Semedi BP, et al.
2026
Diphtheria remains a serious threat and can cause life-threatening complications. We report the case of a 6-year-old girl with severe respiratory and cardiac involvement due to diphtheria. She presented with classic signs, including pseudomembrane, bull neck, lymphadenopathy, and respiratory distress. Corynebacterium diphtheriae var. mitis with a positive toxigenic strain was confirmed. Her condition worsened, requiring intensive care admission and high-flow nasal cannula support. She later developed ventricular tachycardia with hemodynamic instability, which was successfully treated with intravenous magnesium sulfate (MgSO4). The patient recovered with antibiotics, antitoxin, and supportive care. This case highlights the potential for severe diphtheria complications, even with timely treatment. It also suggests a possible role for MgSO4 in managing diphtheria-induced arrhythmias, though further research is needed. Early diagnosis, aggressive management, and continued vaccination efforts are critical to reducing diphtheria-related morbidity and mortality.
Abstract licence: CC BY-NC-SA
Chia TH, Heng ES
2025
Usamatu A, Iseh KR, Amutta SB, et al.
2025
Rubin L, Fowler J, Ranga S, et al.
2025
- Diphtheria
- Botulism
- Malaria
Theobald. Smith
The Journal of Experimental Medicine, 1909
Karen S. Wagner, P. Stickings, Joanne White, et al.
Vaccine, 2009
- Diphtheria
- Biological Products
- Diphtheria Antitoxin
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.